Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | RPL35 |
| Upstream (Parents) |
|---|
| (<<) ACTB → RPL35 |
| (<<) BCL2L1 → RPL35 |
| (<<) CFL1 → RPL35 |
| (<<) CREB1 → RPL35 |
| (<<) CYB5R3 → RPL35 |
| (<<) ENO1 → RPL35 |
| (<<) GAPDH → RPL35 |
| (<<) HSPA8 → RPL35 |
| (<<) KLF6 → RPL35 |
| (<<) PPIF → RPL35 |
| (<<) PPP1CA → RPL35 |
| (<<) RHOA → RPL35 |
| (<<) RXRB → RPL35 |
| (<<) TAGLN2 → RPL35 |
| Downstream (Children) |
|---|
| RPL35 → ANXA2 (>>) |
| RPL35 → ATF4 (>>) |
| RPL35 → EIF6 (>>) |
| RPL35 → FZD3 (>>) |
| RPL35 → GPR150 (>>) |
| RPL35 → GPX1 (>>) |
| RPL35 → GPX4 (>>) |
| RPL35 → HES1 (>>) |
| RPL35 → ID1 (>>) |
| RPL35 → JHDM1D (>>) |
| RPL35 → MAPK1 (>>) |
| RPL35 → MAPKAP1 (>>) |
| RPL35 → MT1F (>>) |
| RPL35 → MT1G (>>) |
| RPL35 → NMU (>>) |
| RPL35 → PLCB3 (>>) |
| RPL35 → RHOV (>>) |
| RPL35 → RPL36 (>>) |
| RPL35 → RPS16 (>>) |
| RPL35 → SFXN4 (>>) |
| RPL35 → SLC25A25 (>>) |
| RPL35 → TUBB2C (>>) |
| RPL35 → TXNIP (>>) |
| RPL35 → UBE2I (>>) |
